iGMDRD49
| Standard Name | CHEMBL | Pubchem CID | KEGG Drug ID | DRUGBANK ID | Drug Status | Drug targets (TTD) | Drug Type |
|---|---|---|---|---|---|---|---|
| Mitomycin | CHEMBL105 | 5746 | D00208 | DB00305 | Alone | DAP001402 | Small Molecule |
Drug Class:
Alkylating AgentsAlkylating DrugAntibiotics, AntineoplasticAntineoplastic AgentsAntineoplastic and Immunomodulating AgentsAzirinesCardiotoxic antineoplastic agentsCross-Linking ReagentsCytotoxic Antibiotics and Related SubstancesEnzyme InhibitorsHeterocyclic CompoundsHeterocyclic Compounds, 1-RingHeterocyclic Compounds, 2-RingImmunosuppressive AgentsIndicators and ReagentsIndolequinonesIndolesLaboratory ChemicalsMitomycinsMyelosuppressive AgentsNoxaeNucleic Acid Synthesis InhibitorsP-glycoprotein/ABCB1 SubstratesQuinonesSpecialty Uses of ChemicalsToxic ActionsDrug Targets:
DNA crosslinkerDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
| Gene ID | Gene Name | Model Num. |
|---|---|---|
| 1105 | CHD1 | 3 |
| 2956 | MSH6 | 1 |
| 6597 | SMARCA4 | 1 |
| 2176 | FANCC | 1 |
| 390502 | SERPINA2 | 1 |
| 10476 | ATP5PD | 1 |
| 5605 | MAP2K2 | 1 |
| 54477 | PLEKHA5 | 2 |
| 23012 | STK38L | 1 |
| 1776 | DNASE1L3 | 1 |
| 6416 | MAP2K4 | 1 |
| 9759 | HDAC4 | 2 |
| 1029 | CDKN2A | 1 |
| 3932 | LCK | 1 |
| 7157 | TP53 | 7 |
| 4086 | SMAD1 | 1 |
| 4026 | LPP | 2 |
| 675 | BRCA2 | 1 |
| 4609 | MYC | 1 |
| 3338 | DNAJC4 | 1 |
| 23742 | NPAP1 | 3 |
| 2317 | FLNB | 3 |
| 5506 | PPP1R3A | 2 |
| 5925 | RB1 | 1 |
| 862 | RUNX1T1 | 2 |
| 5586 | PKN2 | 2 |
| 3488 | IGFBP5 | 1 |
| 79728 | PALB2 | 4 |
| 1803 | DPP4 | 1 |
| 2886 | GRB7 | 3 |
Gene in drug-gene network: Network Plot
Models in Mitomycin

